IQDG Fees and Costs — WisdomTree International Quality Dividend Growth Fund
Data updated: 2026-08-31
The net expense ratio is 0.42%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $470K in broker commissions, 0.0633% of average net assets, and portfolio turnover was 58%.
IQDG Fees and Expenses
Annual operating expenses and sales charges of IQDG. Prospectus, as of March 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.42% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.42% |
| Fee waiver | — |
| Net expense ratio | 0.42% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
IQDG Costs Over Time
On $10,000 invested in IQDG, assuming 5% a year before costs, total costs come to $305 over 5 years, cutting the return by 0.51% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.42%) | $44 | $138 | $241 |
| Trading costs (broker commissions) | $7 | $21 | $36 |
| Lost growth on money paid in costs | $0 | $8 | $28 |
| Total costs | $51 | $167 | $305 |
| Value after costs | $10,449 | $11,409 | $12,457 |
| Impact on return, per year | 0.51% | 0.51% | 0.51% |
IQDG Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0633%
- Total broker commissions: $470K
- Bought from dealers (principal trades, not a cost): $487.7M
- Portfolio turnover (prospectus): 58%
- Securities on loan, average value: $7.2M
- Net income from securities lending: $39K (0.005% of average net assets)
IQDG Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY & CO. LLC | $461K | 98.17% |
| J.P. Morgan Securities LLC | $1K | 0.29% |
| UBS SECURITIES LLC | $1K | 0.26% |
| BARCLAYS CAPITAL, INC. | $1K | 0.25% |
| MACQUARIE CAPITAL (USA), INC. | $1K | 0.23% |
| BOFA SECURITIES, INC. | $1K | 0.21% |
| VIRTU AMERICAS LLC | $998 | 0.21% |
| GOLDMAN SACHS & CO. LLC | $670 | 0.14% |
| INSTINET LLC | $604 | 0.13% |
| CitiGroup Global Markets Inc. | $500 | 0.11% |
IQDG Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY & CO. LLC | $310.2M | 63.60% |
| UBS SECURITIES LLC | $79.7M | 16.33% |
| CitiGroup Global Markets Inc. | $52.1M | 10.67% |
| J.P. Morgan Securities LLC | $32.7M | 6.71% |
| GOLDMAN SACHS & CO. LLC | $7.8M | 1.59% |
| VERALLIA | $3.0M | 0.61% |
| BOFA SECURITIES, INC. | $1.7M | 0.34% |
| Fortnox Finans AB | $491K | 0.10% |
| Biotage AB | $257K | 0.05% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.